WealthBridge Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

WealthBridge Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-735	Closed	-$134K	–	965
2019 Q1	$134K	Buy	735 +55	+8%	+$8.18K	0.09%	150
2018 Q4	$66K	Buy	+680	New	+$89.2K	0.05%	211

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

WealthBridge Capital Management's GWPH Position: Q2 2019 in Review

WealthBridge Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 735 shares — an estimated $134K sold.

WealthBridge Capital Management first reported a position in GWPH in Q4 2018 and held it in 2 quarters. The position peaked at $134K in Q1 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

WealthBridge Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
WealthBridge Capital Management sold 735 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $134K.
WealthBridge Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
WealthBridge Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $134K in Q1 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on WealthBridge Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.